Back
Greek Organisation of Football Prognostics SA Vs. United Therapeutics Industry Stock Comparison
Buy
61
GOFPY
Greek Organisation of Football Prognostics SA
Last Price:
$11.16
Seasonality Move:
-1.19%
Sell
49
UTHR
United Therapeutics
Last Price:
$286.01
Seasonality Move:
8.9%
Buy
61
Greek Organisation of Football Prognostics SA (GOFPY)
is a Buy
Is Greek Organisation of Football Prognostics SA a Buy, Sell or Hold?
-
The current Greek Organisation of Football Prognostics SA [GOFPY] share price is $11.16. The Score for GOFPY is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
GOFPY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
United Therapeutics (UTHR)
is a Sell
Is United Therapeutics a Buy, Sell or Hold?
-
The current United Therapeutics [UTHR] share price is $285.97. The Score for UTHR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
UTHR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GOFPY Stock Price Chart
What is Greek Organisation of Football Prognostics SA's stock price today?
-
The Greek Organisation of Football Prognostics SA share price today is $11.16Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GOFPY is experiencing selling pressure, which indicates risk of future bearish movement.
UTHR Stock Price Chart
What is United Therapeutics's stock price today?
-
The United Therapeutics share price today is $285.97Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UTHR is experiencing selling pressure, which indicates risk of future bearish movement.
GOFPY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 52.81 | Buy |
Chaikin Money Flow: | -46855 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.81 - 11.43) | Buy |
Bollinger Bands (100): | (9.17 - 11.21) | Buy |
UTHR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.81 | Sell |
Relative Strength Index (14 RSI): | 40.9 | Sell |
Chaikin Money Flow: | -196555 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (287.13 - 320.91) | Sell |
Bollinger Bands (100): | (288.07 - 339.05) | Sell |
GOFPY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.98 | Buy |
20-day SMA: | 11.02 | Buy |
50-day SMA: | 11.11 | Buy |
200-day SMA: | 9.31 | Buy |
8-day EMA: | 11 | Buy |
20-day EMA: | 11.04 | Buy |
50-day EMA: | 10.86 | Buy |
200-day EMA: | 9.7 | Buy |
UTHR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 287.95 | Sell |
20-day SMA: | 302.5 | Sell |
50-day SMA: | 300.61 | Sell |
200-day SMA: | 338.56 | Sell |
8-day EMA: | 289.77 | Sell |
20-day EMA: | 296.51 | Sell |
50-day EMA: | 303.03 | Sell |
200-day EMA: | 317.93 | Sell |
Greek Organisation of Football Prognostics SA Earnings Growth & GOFPY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
United Therapeutics Earnings Growth & UTHR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.69 per share, an increase next quarter of $0.24 per share, an increase this year of $2.46 per share, and an increase next year of $1.06 per share.
Greek Organisation of Football Prognostics SA Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
United Therapeutics Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |